Emi Nakatsugawa
Overview
Explore the profile of Emi Nakatsugawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakaguchi K, Naito T, Hoshikawa K, Miyadera Y, Tanaka H, Nakatsugawa E, et al.
Drug Metab Pharmacokinet
. 2024 Oct;
58:101027.
PMID: 39428315
Factors that determine clinical responses to vonoprazan remain unknown. This study aimed to characterize plasma vonoprazan and CYP3A activity using its endogenous marker and genetic variants in patients with digestive...
2.
Terasawa M, Shibata K, Mimura A, Nakatsugawa E, Takahashi K, Nakamura T, et al.
Ther Drug Monit
. 2024 Jul;
PMID: 39023376
No abstract available.
3.
Nakatsugawa E, Naito T, Shibata K, Kitajima R, Kawakami J
Fundam Clin Pharmacol
. 2024 Jan;
38(3):596-605.
PMID: 38192190
Background/objectives: Clinical responses to naldemedine vary between individuals with advanced cancer. This is a prospective, single-center, observational study aimed to evaluate the influence of genetic polymorphisms and cachexia status on...
4.
Nakatsugawa E, Naito T, Imoto Y, Shibata K, Ono T, Kawakami J
J Infect Chemother
. 2022 Nov;
29(3):244-249.
PMID: 36410672
Background: Long-term use of itraconazole (ITZ) is associated with a risk of inducing hepatotoxicity. This study aimed to evaluate the associations of plasma concentrations of ITZ and its hydroxylated metabolite...